Timing update ... "While Chuck Schumer made clear that public input is valued—and they’ve created an email account where people can submit comments until September 30 on the proposal—the new comments provide a fresh insight into the legislative process to build support for the measure within the Senate."
IMO, expect legislation to gain momentum in October after the comment period ends.
Valens is positioned to take advantage of USA legalization, so IMO Valens will see PPS progress soon thereafter at a valuation more in line with USA MSO's.
If that's so, then the Valens PPS gains may be great by comparison.
Regardless, I am looking forward to the next ER. They should easily top $25M